Literature DB >> 762214

High-performance liquid chromatographic assay for allopurinol and oxipurinol in human plasma.

W G Kramer, S Feldman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 762214     DOI： 10.1016/s0378-4347(00)82068-x

Source DB:  PubMed          Journal:  J Chromatogr


× No keyword cloud information.
  5 in total

1.  The role of metabolites in bioequivalency assessment. I. Linear pharmacokinetics without first-pass effect.

Authors:  M L Chen; A J Jackson
Journal:  Pharm Res       Date:  1991-01       Impact factor: 4.200

2.  Allopurinol dosage selection: relationships between dose and plasma oxipurinol and urate concentrations and urinary urate excretion.

Authors:  R O Day; J O Miners; D J Birkett; A Whitehead; D Naidoo; J Hayes; E Savdie
Journal:  Br J Clin Pharmacol       Date:  1988-10       Impact factor: 4.335

3.  Relationship between plasma oxipurinol concentrations and xanthine oxidase activity in volunteers dosed with allopurinol.

Authors:  R O Day; J Miners; D J Birkett; G G Graham; A Whitehead
Journal:  Br J Clin Pharmacol       Date:  1988-10       Impact factor: 4.335

4.  Does benzbromarone in therapeutic doses raise renal excretion of oxipurinol?

Authors:  D P Mertz; R Eichhorn
Journal:  Klin Wochenschr       Date:  1984-12-17

5.  Kinetics of allopurinol after single intravenous and oral doses. Noninteraction with benzbromarone and hydrochlorothiazide.

Authors:  B Breithaupt; M Tittel
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.